Logistical Nightmare

May 10, 2016

Today’s most innovative medical breakthroughs, including cell therapies, tissue engineering, gene-modified cell therapies and genome editing therapies have three things in common: They are complicated, very expensive to produce and extremely temperature-sensitive. In this informative article published in Pharmaceutical Manufacturing and Packing Sourcer (PMPS), Cryoport Chief Commercial Officer Mark Sawicki, Ph.D., examines logistics planning and risk mitigation as they pertain to clinical trials; the impact of cold chain transportation on data integrity; and the regulatory landscape. Read more >

Questions or comments? We welcome your feedback!

Email Us

Tags: Temperature Controlled Logistics, Frozen Biological Shipping